KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Unitedhealth (UNH) Interest Expenses (2016 - 2025)

Unitedhealth (UNH) has disclosed Interest Expenses for 17 consecutive years, with $974.0 million as the latest value for Q4 2025.

  • Quarterly Interest Expenses fell 2.89% to $974.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.0 billion through Dec 2025, up 2.46% year-over-year, with the annual reading at $4.0 billion for FY2025, 2.46% up from the prior year.
  • Interest Expenses for Q4 2025 was $974.0 million at Unitedhealth, down from $1.0 billion in the prior quarter.
  • The five-year high for Interest Expenses was $1.1 billion in Q3 2024, with the low at $397.0 million in Q1 2021.
  • Average Interest Expenses over 5 years is $745.3 million, with a median of $829.0 million recorded in 2023.
  • The sharpest move saw Interest Expenses dropped 9.15% in 2021, then soared 77.3% in 2023.
  • Over 5 years, Interest Expenses stood at $431.0 million in 2021, then surged by 56.84% to $676.0 million in 2022, then grew by 22.78% to $830.0 million in 2023, then rose by 20.84% to $1.0 billion in 2024, then decreased by 2.89% to $974.0 million in 2025.
  • According to Business Quant data, Interest Expenses over the past three periods came in at $974.0 million, $1.0 billion, and $1.0 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.